Paclitaxel liposomal bulk supplier for pharma manufacturers

Paclitaxel Liposomal Suppliers & Bulk Manufacturers

Available Forms: Injection (IV administration)

Available Strengths: 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL

Reference Brands: Taxol®, Abraxane® (US & EU)

Paclitaxel (brands Taxol® and Abraxane®) is an essential chemotherapy agent used for breast, ovarian, and lung cancer. Available in IV injection forms, with strengths like 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL, Paclitaxel stabilizes microtubules to halt cancer cell division. Sourced globally by B2B pharma suppliers, it is GMP-compliant and widely available in the US and EU.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Paclitaxel, marketed as Taxol® and Abraxane®, is a critical chemotherapy agent used to treat various cancers, including ovarian, breast, and lung cancer. Available in IV injection forms, with strengths like 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL, Paclitaxel works by stabilizing microtubules to prevent cell division. Widely sourced by B2B pharmaceutical suppliers globally, Paclitaxel ensures GMP-compliant manufacturing and reliable supply to hospitals and oncology centers in the US and EU. With competitive pricing, it is a vital component in cancer treatment regimens, providing effective therapy for aggressive cancers.

Paclitaxel Liposomal — third party manufacturing & bulk supply

Paclitaxel Liposomal is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Paclitaxel Liposomal is supplied as Injection (IV administration) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Paclitaxel Liposomal listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Paclitaxel Liposomal →

Back to Listing

Frequently Asked Questions

Paclitaxel liposomal is listed as Injection (IV administration) in 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Paclitaxel liposomal is referenced against Taxol®, Abraxane® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.